Skip to content

A Dyadic Intervention for Young Adult Patients With Cancer and Their Partner Caregivers

A Dyadic Intervention for Young Adult Patients With Cancer and Their Partner Caregivers

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06172907
Acronym
YAD
Enrollment
20
Registered
2023-12-15
Start date
2024-04-19
Completion date
2026-12-31
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Caregiver Burden, Coping Skills, Couples, Psychological Distress, Survivorship

Keywords

Young Adult Cancer, Cancer Caregiving

Brief summary

The purpose of this pilot study is to examine the feasibility and acceptability of a brief psychotherapy intervention to improve psychosocial coping and maintain couple relationships among young adults (aged 25-39) with cancer and their caregiving partners.

Detailed description

Young adults (YA) with cancer have unique challenges in coping, and their primary partners may experience burden and low self-efficacy related to caregiving. In this single-arm pilot trial, the investigators shall deliver an eight-session intervention to YAs with cancer and their self-identified partners who provide caregiving. The intervention is founded on principles from cognitive-behavioral therapy and couples-focused interventions, tailored for YA. The aim of the study is to assess the feasibility and acceptability of the intervention, which will inform refinements prior to a larger-scale clinical trial. This study will include 10 YAs and their partner-caregivers (N=20). Participants will complete surveys at baseline and after the intervention, and will be invited to complete optional semi-structured exit interviews.

Interventions

BEHAVIORALYoung Adults Coping with Cancer Together Intervention

This intervention is based on cognitive-behavioral therapy and couples' therapy. It aims to improve cancer and caregiving-related self-efficacy and coping, as well as promote relationship maintenance in context of cancer. The intervention will be delivered by a trained mental health practitioner and include didactics, experiential exercises, and home practice.

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Single-Arm Pilot Study

Eligibility

Sex/Gender
ALL
Age
25 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

* Either: (1) Currently receiving active cancer treatment (n=5) or are within two years of completing active treatment (n=5) at Massachusetts General Cancer Center (MGHCC), located in Boston, Massachusetts, United States, OR (2) are the partner of an individual between the ages of 25-39 who is currently receiving treatment at MGHCC (n=5) or who has completed cancer treatment at MGHCC within the past two years (n=5) * Either: (1) Indicates a score ≥4 on the National Comprehensive Cancer Network (NCCN) adapted distress thermometer study screening questions, OR (2) are the partner of a participant indicating a score ≥4 on the NCCN adapted distress thermometer study screening questions * English-speaking

Exclusion criteria

• Uncontrolled psychosis, active suicidal ideation, or cognitive impairment

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of Intervention14 +/- 2 WeeksFeasibility will be measured by measured by participant rates of enrollment (≥50% of those eligible), participant retention (≥70% of those enrolled), and intervention attendance (≥70% attending at least 6 of 8 sessions).
Acceptability of Intervention14 +/- 2 WeeksAcceptability with be measured by satisfaction with the intervention as rated on the Client Satisfaction Questionnaire. The intervention will be deemed acceptable if ≥75% of participants report average satisfaction that exceeds the CSQ's midpoint.

Countries

United States

Contacts

Primary ContactJamie M Jacobs, Ph.D.
jjacobs@mgh.harvard.edu617-643-1777
Backup ContactZeba N Ahmad, Ph.D.
zahmad2@mgh.harvard.edu617-724-1586

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026